Masaaki Mori;Shinichi Watabe;Tomoaki Taguchi;Hisaya Hasegawa;Mika Ishige;Naoyuki Tanuma;Akihiro Hirakawa;Ryuji Koike;Satoshi Kusuda; (2021). Study protocol: a multicenter, uncontrolled, open-label study of palivizumab in neonates, infants, and preschool children at high risk of severe respiratory syncytial virus infection . BMC Pediatrics, (), –.
doi:10.1186/s12887-021-02567-6
url to share this paper:
An interview with Sci-Hub Founder Alexandra Elbakyan Who exactly should pay for academic research